ホーム 計算ツール
代理店ログイン

検索結果

Search Results for " 666 15 "

ターゲット

3

阻害剤

4

リコンビナントタンパク質

カタログ番号 製品名 別名 ターゲット
T5318 666-15 CREB inhibitor Epigenetic Reader Domain
666-15 (CREB inhibitor) is a potent and selective CREB inhibitor (IC50: 81 nM).
T8890 653-47 hydrochloride Epigenetic Reader Domain
653-47 hydrochloride is a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15. It is also a very weak CREB inhibitor with IC50 of 26.3 μM.
T8889 653-47
653-47 acts as a potentiator significantly enhancing the inhibitory activity of 666-15 on the cAMP-response element binding protein (CREB), while it also exhibits mild CREB inhibitory properties itself, with an IC50 valu...

Recombinant Proteins

カタログ番号 製品名 Species Expression System
TMPY-00803 Fibronectin Protein, Human, Recombinant (aa 607-1265, His) Human HEK293 Cells
Fibronectin Protein, Human, Recombinant (aa 607-1265, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 73.2 kDa and the accession number is P02751-15.
TMPY-05562 Fibronectin Protein, Human, Recombinant (aa 1722-1811, His) Human HEK293 Cells
Fibronectin Protein, Human, Recombinant (aa 1722-1811, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 11.3 kDa and the accession number is P02751-15.
TMPK-01412 HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi) Human HEK293 Cells
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 we...
TMPK-01416 HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi), Biotinylated Human HEK293 Cells
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 we...